NEW YORK (GenomeWeb News) — Alnylam said today it has granted a non-exclusive license for its Kreutzer-Limmer siRNA patents to Hayashi Kasei, an siRNA supplier in Japan and Korea.
 
Under the agreement, the Osaka, Japan-based Hayashi Kasei will be able to use the siRNAi patents to provide RNAi research products and services, Alnylam said.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.